NCT00287339View on ClinicalTrials.gov

The Utility of Nexium in Chronic Cough and Reflux Disease

PHASE4CompletedINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

September 30, 2005

Primary Completion Date

September 30, 2008

Study Completion Date

September 30, 2008

Conditions
CoughGERD
Interventions
DRUG

Esomeprazole

40mg capsule BID for 12 weeks

DRUG

Placebo

placebo capsule BID for 12 weeks

Trial Locations (1)

27599

UNC Gastroenterology, UNC Pulmonology, UNC ENT, Chapel Hill

Sponsors

Collaborators (1)

AstraZeneca
All Listed Sponsors
collaborator

AstraZeneca

INDUSTRY

lead

University of North Carolina, Chapel Hill

OTHER

NCT00287339 - The Utility of Nexium in Chronic Cough and Reflux Disease | Biotech Hunter | Biotech Hunter